SLVM Stock Analysis: Sylvamo | NYSE
Paper & Paper Products | NYSE, USA | Market Cap: 1.532m USD | 12M Return: -11% | US8713321029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.1M
EPS Trend: -84.1%
Qual. Beats: 1
Rev. Trend: -91.5%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
Seasonality 5.1 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Sylvamo Corporation is a global producer of uncoated freesheet paper, operating in Europe, Latin America, and North America. The company manufactures copy, tinted, and colored laser printing paper under the REY brand, graphic and inkjet papers under the Berga brand, and office and digital printing papers under the Multicopy brand. It also sells uncoated freesheet under brands including Chamex, Chamequinho, Chambril, Hammermill, Springhill, Williamsburg, Accent, DRM, and Postmark. Sylvamo operates both integrated mills (which produce pulp from wood fiber) and non-integrated mills (which purchase market pulp), and distributes its products through retail, merchant, and e-commerce channels to converters, agents, resellers, and paper distributors.
The company was founded in 1898 and is headquartered in Memphis, Tennessee. Sylvamo was spun off from International Paper in October 2021 as an independent, publicly traded entity focused exclusively on uncoated freesheet paper, a commodity segment of the broader paper products industry that has faced long-term demand pressure from digital substitution in office and print applications.
- European pulp and uncoated freesheet prices rebound on demand recovery
- Latin America copy paper demand supports Chamex brand revenue growth
- North American office printing volumes decline as remote work persists
| Net Income: -180.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -5.21 > 1.0 |
| NWC/Revenue: 10.14% < 20% (prev 9.82%; Δ 0.32% < -1%) |
| CFO/TA 0.06 > 3% & CFO 186.0m > Net Income -180.0m |
| Net Debt (907.0m) to EBITDA (333.0m): 2.72 < 3 |
| Current Ratio: 1.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (40.0m) vs 12m ago -2.68% < -2% |
| Gross Margin: 17.18% > 18% (prev 20.02%; Δ -2.84% > 0.5%) |
| Asset Turnover: 109.5% > 50% (prev 126.9%; Δ -17.42% > 0%) |
| Interest Coverage Ratio: 4.0 > 6 (EBIT TTM 168.0m / Interest Expense TTM 42.0m) |
| A: 0.11 (Total Current Assets 1.38b - Total Current Liabilities 1.06b) / Total Assets 2.95b |
| B: 0.76 (Retained Earnings 2.25b / Total Assets 2.95b) |
| C: 0.06 (EBIT TTM 168.0m / Avg Total Assets 2.83b) |
| D: 0.33 (Book Value of Equity 740.0m / Total Liabilities 2.21b) |
| Altman-Z'' = 3.93 = AA |
| DSRI: 0.82 (Receivables 303.0m/411.0m, Revenue 3.10b/3.43b) |
| GMI: 1.17 (GM 20.02% / 17.18%) |
| AQI: 2.28 (AQ_t 0.20 / AQ_t-1 0.09) |
| SGI: 0.90 (Revenue 3.10b / 3.43b) |
| TATA: -0.12 (NI -180.0m - CFO 186.0m) / TA 2.95b) |
| Beneish M = -2.35 (Cap -4..+1) = BBB |
As of November 17, 2026, the stock is trading at USD 38.82 with a total of 332,340 shares traded. Over the past week, the price has changed by +2.16%, over one month by +18.46%, over three months by +8.03% and over the past year by -11.03%.
Current recommended Stop Loss: 35.80 (which is 7.8% or 1.7 ATR below the current price).
Sylvamo has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy SLVM.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 46 | 18.5% |
P/E Trailing = 10.2747
P/E Forward = 7.728
P/S = 0.4683
P/B = 2.0729
Revenue TTM = 3.10b USD
EBIT TTM = 168.0m USD
EBITDA TTM = 333.0m USD
Long Term Debt = 861.0m USD (from longTermDebt, last quarter)
Short Term Debt = 139.0m USD (from shortTermDebt, last quarter)
Debt = 1.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 907.0m USD (calculated: Debt 1.00b - CCE 93.0m)
Enterprise Value = 2.44b USD (1.53b + Debt 1.00b - CCE 93.0m)
Interest Coverage Ratio = 4.0 (Ebit TTM 168.0m / Interest Expense TTM 42.0m)
EV/FCF = -64.19x (Enterprise Value 2.44b / FCF TTM -38.0m)
FCF Yield = -1.56% (FCF TTM -38.0m / Enterprise Value 2.44b)
FCF Margin = -1.23% (FCF TTM -38.0m / Revenue TTM 3.10b)
Net Margin = -5.81% (Net Income TTM -180.0m / Revenue TTM 3.10b)
Gross Margin = 17.18% ((Revenue TTM 3.10b - Cost of Revenue TTM 2.56b) / Revenue TTM)
Gross Margin QoQ = 12.71% (prev 16.38%)
Tobins Q-Ratio = 0.83 (Enterprise Value 2.44b / Total Assets 2.95b)
Interest Expense / Debt = 4.20% (Interest Expense 42.0m / Debt 1.00b)
Taxrate = 16.13% (20.0m / 124.0m)
NOPAT = 140.9m (EBIT 168.0m * (1 - 16.13%))
Current Ratio = 1.29 (Total Current Assets 1.38b / Total Current Liabilities 1.06b)
Debt / Equity = 1.35 (Debt 1.00b / totalStockholderEquity, last quarter 740.0m)
Debt / EBITDA = 2.72 (Net Debt 907.0m / EBITDA 333.0m)
Debt / FCF = -23.87 (negative FCF - burning cash) (Net Debt 907.0m / FCF TTM -38.0m)
Total Stockholder Equity = 910.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.37% (Net Income -180.0m / Total Assets 2.95b)
RoE = -19.78% (Net Income TTM -180.0m / Total Stockholder Equity 910.0m)
RoCE = 9.49% (EBIT 168.0m / Capital Employed (Equity 910.0m + L.T.Debt 861.0m))
RoIC = 7.29% (NOPAT 140.9m / Invested Capital 1.93b)
WACC = 5.80% (E(1.53b)/V(2.53b) * Re(7.29%) + D(1.00b)/V(2.53b) * Rd(4.20%) * (1-Tc(0.16)))
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.45 | Cagr: -2.04%
[DCF] Fair Price = unknown (Cash Flow -38.0m)
EPS Correlation: -84.07 | EPS CAGR: -37.07% | SUE: 1.71 | # QB: 1
Revenue Correlation: -91.46 | Revenue CAGR: -6.51% | SUE: -4.0 | # QB: -1
EPS current Quarter (2027-03-31): EPS=0.83 | Chg30d=+51.82% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=2.33 | Chg30d=+51.96% | Revisions=+0% | GrowthEPS=-34.3% | GrowthRev=-23.4%
EPS next Year (2027-12-31): EPS=4.65 | Chg30d=-10.58% | Revisions=-17% | GrowthEPS=+100.0% | GrowthRev=-1.2%
[Analyst] Revisions Ratio: +0% (up=3, down=3)